New imaging study aims to personalize prostate cancer treatment
NCT ID NCT05819606
First seen Nov 01, 2025 · Last updated May 21, 2026 · Updated 29 times
Summary
This study looked at 70 men with newly diagnosed intermediate or high-risk prostate cancer. Researchers used special PET scans and blood tests to see if they could better predict how aggressive the cancer is. The goal is to help doctors choose the most effective treatment for each patient.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
GSTeP FPG Policlinico Gemelli IRCCS
Roma, 00168, Italy
Conditions
Explore the condition pages connected to this study.